Targeting sepsis, the leading cause of ICU deaths

One obstacle to therapeutic use of microRNAs (miRNA), which are in clinical trial for a number of diseases, are ribonucleases, whose job it is to destroy them. Researchers report that an miRNA protective against sepsis can be delivered effectively via a nanocarrier.